Martine Rothblatt's Securities Transactions in United Therapeutics Corp

The filing details the securities transactions of Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp. The filing includes information on securities to be sold and recent transactions over the past three months. Rothblatt plans to sell 4,000 common shares on October 16, 2025, with an aggregate market value of $1,725,252.40. Additionally, the filing outlines multiple sales of common shares between September 9, 2025, and October 15, 2025, totaling significant gross proceeds. The transactions are part of an Executive Deferred Compensation plan, and the securities were acquired on March 15, 2016. The filing also provides details on the broker involved, TD Securities (USA) LLC.